Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Altamura

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
The American Journal of Psychiatry|March 4, 2003
Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorderAlessandro Bertolino, Domenico Sciota, Flora Brudaglio, et al.
Expert Opinion on Biological Therapy|February 5, 2025
Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's diseaseFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Brain Sciences|July 29, 2023
Coping as a Mediator between Attachment and Depressive Symptomatology Either in Pregnancy or in the Early Postpartum Period: A Structural Equation Modelling ApproachMario Altamura, Ivana Leccisotti, Laura De Masi, et al.
Neuroimage. Clinical|September 12, 2018
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates studyGiulia M Giordano, Thomas Koenig, Armida Mucci, et al.
Brain Sciences|April 27, 2024
Exploring the Relationship between Neuroticism and Perinatal Depressive Symptoms: Findings from a 2-Year, Multicenter Study in ItalyMelania Severo, Annamaria Petito, Antonio Ventriglio, et al.
Expert Review of Neurotherapeutics|May 2, 2025
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges aheadMadia Lozupone, Vittorio Dibello, Emanuela Resta, et al.
Expert Opinion on Investigational Drugs|July 5, 2023
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathiesFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Investigational Drugs|June 27, 2022
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's diseaseMadia Lozupone, Giuseppe Berardino, Anita Mollica, et al.
Schizophrenia (Heidelberg, Germany)|February 21, 2023
Similarities and differences between multivariate patterns of cognitive and socio-cognitive deficits in schizophrenia, bipolar disorder and related riskAlessandra Raio, Giulio Pergola, Antonio Rampino, et al.
NPJ Cardiovascular Health|March 3, 2026
Psychological profile of patients with Brugada syndrome and the impact of its diagnosis and managementFrancesco Santoro, Luigi Di Biase, Antonio Curcio, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
The American Journal of Psychiatry|March 4, 2003
Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorderAlessandro Bertolino, Domenico Sciota, Flora Brudaglio, et al.
Expert Opinion on Biological Therapy|February 5, 2025
Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's diseaseFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Brain Sciences|July 29, 2023
Coping as a Mediator between Attachment and Depressive Symptomatology Either in Pregnancy or in the Early Postpartum Period: A Structural Equation Modelling ApproachMario Altamura, Ivana Leccisotti, Laura De Masi, et al.
Neuroimage. Clinical|September 12, 2018
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates studyGiulia M Giordano, Thomas Koenig, Armida Mucci, et al.
Brain Sciences|April 27, 2024
Exploring the Relationship between Neuroticism and Perinatal Depressive Symptoms: Findings from a 2-Year, Multicenter Study in ItalyMelania Severo, Annamaria Petito, Antonio Ventriglio, et al.
Expert Review of Neurotherapeutics|May 2, 2025
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges aheadMadia Lozupone, Vittorio Dibello, Emanuela Resta, et al.
Expert Opinion on Investigational Drugs|July 5, 2023
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathiesFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Investigational Drugs|June 27, 2022
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's diseaseMadia Lozupone, Giuseppe Berardino, Anita Mollica, et al.
Schizophrenia (Heidelberg, Germany)|February 21, 2023
Similarities and differences between multivariate patterns of cognitive and socio-cognitive deficits in schizophrenia, bipolar disorder and related riskAlessandra Raio, Giulio Pergola, Antonio Rampino, et al.
NPJ Cardiovascular Health|March 3, 2026
Psychological profile of patients with Brugada syndrome and the impact of its diagnosis and managementFrancesco Santoro, Luigi Di Biase, Antonio Curcio, et al.
Pageof 8